S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Halper Sadeh Launches Investigation into Filana Therapeutics Leadership

The New York-based investor rights firm Halper Sadeh LLC has initiated an investigation into potential breaches of fiduciary duty by officers and directors at Filana Therapeutics, Inc. The inquiry focuses on whether current leadership failed to protect shareholder interests, potentially opening doors for corporate governance reforms.

Halper Sadeh Launches Investigation into Filana Therapeutics Leadership
Photo: Bio & News

Long-term shareholders of the NASDAQ-listed company may be eligible to seek legal remedies, including the recovery of funds for the firm or court-approved financial incentives. The investigation, announced on August 12, 2026, aims to determine if management’s actions compromised organizational transparency or oversight, effectively eroding value for those holding FLNA stock.

Attorneys Daniel Sadeh and Zachary Halper are leading the outreach, inviting investors to review their rights regarding corporate misconduct. The firm operates on a contingent fee basis, meaning shareholders face no out-of-pocket costs to participate in the legal assessment. Interested parties are encouraged to reach out to the firm’s One World Trade Center office to discuss potential claims and the path toward institutional accountability.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!